Is increased colorectal screening effective in preventing distant disease?

PLoS ONE

Volumn 13, Issue 7, 2018, Pages

  Augustus, Gaius Julian ^a,b   Roe, Denise J ^b   Jacobs, Elizabeth T ^b   Lance, Peter ^b   Ellis, Nathan A ^b  

^a Cancer Biology Graduate Interdisciplinary Program   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MALE; METASTASIS; MIDDLE AGED; RACE; SEX; TUMOR LOCALIZATION; AGED; COLONOSCOPY; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; UNITED STATES;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; SEER PROGRAM; UNITED STATES;

EID: 85050883732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0200462     Document Type: Article

References (36)

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67: 7–30. https://doi.org/10.3322/caac.21387 PMID: 28055103
2. Leslie A, Carey FA, Pratt NR, Steele RJC. The colorectal adenoma-carcinoma sequence. British Journal of Surgery. 2002. pp. 845–860. https://doi.org/10.1046/j.1365-2168.2002.02120.x PMID: 12081733
3. US Preventive Services Task Force. Screening for Colorectal Cancer. JAMA. Agency for Healthcare Research and Quality, Rockville, MD; 2016;315: 2564–2575. https://doi.org/10.1001/jama.2016.5989
4. Kaminski MF, Wieszczy P, Rupinski M, Wojciechowska U, Didkowska J, Kraszewska E, et al. Increased Rate of Adenoma Detection Associates With Reduced Risk of Colorectal Cancer and Death. Gastroen-terology. 2017; 153: 98–105. https://doi.org/10.1053/j.gastro.2017.04.006 PMID: 28428142
5. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based Report. Atlanta (GA); 2017.
6. Shaukat A, Mongin SJ, Geisser MS, Lederle F A, Bond JH, Mandel JS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013; 369: 1106–1114. https://doi.org/10.1056/NEJMoa1300720 PMID: 24047060
7. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy. N Engl J Med. Massachusetts Medical Society; 2013; 369: 1095–1105. https://doi.org/10.1056/NEJMoa1301969 PMID: 24047059
8. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017; 67: 177–193. https://doi.org/10.3322/caac.21395 PMID: 28248415
9. Coughlin SS, Blumenthal DS, Seay SJ, Smith SA. Toward the Elimination of Colorectal Cancer Disparities Among African Americans. J Racial Ethn Heal Disparities. 2016; 3: 555–564. https://doi.org/10.1007/s40615-015-0174-z PMID: 27294749
10. Jerant AF, Fenton JJ, Franks P. Determinants of Racial/Ethnic Colorectal Cancer Screening Disparities. Arch Intern Med. American Medical Association; 2008; 168: 1317. https://doi.org/10.1001/archinte.168.12.1317 PMID: 18574089
11. Augustus GJ, Ellis NA. Race in Cancer Health Disparities Theme Issue Colorectal Cancer Disparity in African Americans: Risk Factors and Carcinogenic Mechanisms. Am J Pathol. Elsevier; 2017; https://doi.org/10.1016/J.AJPATH.2017.07.023
12. Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013. J Natl Cancer Inst. US Department of Health and Human Services, CDC, Atlanta, GA; 2017; 109: djw322. https://doi.org/10.1093/jnci/djw322 PMID: 28376186
13. Centers for Disease Control and Prevention (CDC). Trends in cancer screening—United States, 1987 and 1992. MMWR. 1996; 45: 57–61. PMID: 8544808
14. Centers for Disease Control and Prevention (CDC). Use of colorectal cancer tests—United States, 2002, 2004, and 2006. MMWR. 2008; 57: 253–258. PMID: 18340331
15. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Br Med J. 2014; 348:g2467. https://doi.org/10.1136/bmj.g2467PMID: 24922745
16. Austin H, Henley SJ, King J, Richardson LC, Eheman C. Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening HHS Public Access. Cancer Causes Control. 2014; 25: 191–201. https://doi.org/10.1007/s10552-013-0321-y PMID: 24249437
17. Friis R, Sellers T. Epidemiology for public health practice. 5th ed. Burlington, MA: Jones & Bartlett Learning; 2014.
18. Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol. NIH Public Access; 2010; 37: 202–15. https://doi.org/10.1053/j.seminoncol.2010.05.006 PMID: 20709205
19. Thibodeau S, Bren G, Schaid D. Microsatellite Instability in Cancer of the Proximal Colon. Science. 1993; 260: 816–819. https://doi.org/10.1126/science.8484122 PMID: 8484122
20. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. American Association for Cancer Research; 1997; 57: 808–11. PMID: 9041175
21. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa J-PJ, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Genetics. 1998; 95: 6870–6875.
22. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. American Association for Cancer Research; 1998; 58: 3455–60. PMID: 9699680
23. Veigl ML, Kasturi L, Olechnowicz J, Ma A, Lutterbaugh JD, Periyasamy S, et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Genet Contrib by Paul L Modrich. 1998; 95: 8698–8702.
24. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. Nature Publishing Group; 2006; 38: 787–793. https://doi.org/10.1038/ng1834 PMID: 16804544
25. Arain M A, Sawhney M, Sheikh S, Anway R, Thyagarajan B, Bond JH, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010; 105: 1189–95. https://doi.org/10.1038/ajg.2009.699 PMID: 20010923
26. Chao A, Gilliland F, Willman C, Joste N, Chen IM, Stone N, et al. Patient and tumor characteristics of colon cancers with microsatellite instability: A population-based study. Cancer Epidemiol Biomarkers Prev. 2000; 9: 539–544. PMID: 10868685
27. Bond CE, McKeone DM, Kalimutho M, Bettington ML, Pearson S-A, Dumenil TD, et al. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Oncotarget. Impact Journals, LLC; 2016; 7: 70589–70600. https://doi.org/10.18632/oncotarget.12130 PMID: 27661107
28. Edelstein DL, Axilbund J, Baxter M, Hylind LM, Romans K, Griffin CA, et al. Rapid development of colorectal neoplasia in patients with Lynch syndrome. Clin Gastroenterol Hepatol. NIH Public Access; 2011; 9: 340–3. https://doi.org/10.1016/j.cgh.2010.10.033 PMID: 21070872
29. Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. NIH Public Access; 2015; 110: 223–62; quiz 263. https://doi.org/10.1038/ajg.2014.435 PMID: 25645574
30. Colditz GA, Wolin KY, Gehlert S. Applying What We Know to Accelerate Cancer Prevention. Sci Transl Med. 2012; 4: 127rv4–127rv4. https://doi.org/10.1126/scitranslmed.3003218 PMID: 22461645
31. Emmons KM, Colditz GA. Realizing the Potential of Cancer Prevention—The Role of Implementation Science. N Engl J Med. 2017; 376: 986–990. https://doi.org/10.1056/NEJMsb1609101 PMID: 28273020
32. Pabby A, Schoen RE, Weissfeld JL, Burt R, Kikendall JW, Lance P, et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc. 2005; 61: 385–391. PMID: 15758908
33. Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, John A, Schatzkin A, et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014; 63: 949–956. https://doi.org/10.1136/gutjnl-2012-303796 PMID: 23793224
34. Song M, Giovannucci E. Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United States. JAMA Oncol. American Medical Association; 2016; 2: 1154–1161. https://doi.org/10.1001/jamaoncol.2016.0843 PMID: 27196525
35. Sanduleanu S, Masclee AM, Meijer GA. Interval cancers after colonoscopy—insights and recommendations. Nat Publ Gr. 2012; 9. https://doi.org/10.1038/nrgastro.2012.136 PMID: 22907162
36. Welch HG, Robertson DJ. Colorectal Cancer on the Decline—Why Screening Can’t Explain It All. N Engl J Med. Massachusetts Medical Society; 2016; 374: 1605–1607. https://doi.org/10.1056/NEJMp1600448 PMID: 27119236